home / stock / swtx / swtx quote
Last: | $ |
---|---|
Change Percent: | 9.36% |
Open: | $30.72 |
Close: | $33.30 |
High: | $34.35 |
Low: | $29.41 |
Volume: | 169,218 |
Last Trade Date Time: | 02/12/2020 04:43:31 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $30.72 | $33.30 | $34.35 | $29.41 | 169,218 | 02-12-2020 |
$ | $31.22 | $30.45 | $31.63 | $30.01 | 44,386 | 02-11-2020 |
$ | $33.02 | $31.02 | $33.35 | $30.73 | 71,238 | 02-10-2020 |
$ | $32.50 | $33.02 | $33.785 | $31.4876 | 56,423 | 02-07-2020 |
$ | $34.00 | $32.45 | $34.00 | $32.25 | 30,320 | 02-06-2020 |
$ | $33.73 | $33.90 | $34.52 | $32.52 | 33,281 | 02-05-2020 |
$ | $34.12 | $33.41 | $34.12 | $32.70 | 29,041 | 02-04-2020 |
$ | $32.02 | $33.70 | $34.00 | $31.4268 | 73,710 | 02-03-2020 |
$ | $33.83 | $31.48 | $34.10 | $30.99 | 63,368 | 01-31-2020 |
$ | $36.20 | $33.77 | $36.8399 | $33.31 | 68,905 | 01-30-2020 |
$ | $35.56 | $36.26 | $37.02 | $34.22 | 50,914 | 01-29-2020 |
$ | $38.50 | $35.68 | $38.50 | $34.19 | 74,446 | 01-28-2020 |
$ | $33.92 | $38.29 | $38.89 | $33.01 | 143,590 | 01-27-2020 |
$ | $35.55 | $34.52 | $36.00 | $34.08 | 49,811 | 01-24-2020 |
$ | $34.30 | $35.55 | $36.1368 | $33.84 | 47,571 | 01-23-2020 |
$ | $35.64 | $34.78 | $36.36 | $34.01 | 105,892 | 01-22-2020 |
$ | $35.84 | $35.52 | $36.08 | $34.8005 | 76,149 | 01-21-2020 |
$ | $36.01 | $35.47 | $36.39 | $34.92 | 46,605 | 01-20-2020 |
$ | $36.01 | $35.47 | $36.39 | $34.92 | 46,605 | 01-17-2020 |
$ | $34.84 | $35.77 | $36.00 | $33.625 | 201,930 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
SpringWorks Therapeutics Inc. Company Name:
SWTX Stock Symbol:
NYSE Market:
– Results from Phase 2b ReNeu trial of mirdametinib in NF1-PN accepted for oral presentation – – Additional data from the Phase 3 DeFi trial of OGSIVEO® (nirogacestat) in adults with desmoid tumors also accepted for presentations at ASCO – STAMF...
STAMFORD, Conn., April 18, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), a commercial-stage biopharmaceutical company f...
STAMFORD, Conn., April 18, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that it will host a live conference call and webcast at 8:30 a.m. E.T. on Thursday, May 2, 20...